Zondervan K T, Missmer S, Abrao M S, Einarsson J I, Horne A W, Johnson N P, Lee T T M, Petrozza J, Tomassetti C, Vermeulen N, Grimbizis G, De Wilde R L
Facts Views Vis Obgyn. 2022 Mar;14(1):5-15. doi: 10.52054/FVVO.14.1.001. Epub 2022 Mar 1.
In the field of endometriosis, several classification, staging and reporting systems have been developed and published, but there are no data on the uptake of these systems in clinical practice.
The objective of the current study was to examine whether clinicians routinely use the existing endometriosis classification systems, which system do they use and what are the clinicians’ motivations?
A cross-sectional study was performed to gather data on the current use of endometriosis classification systems, problems encountered and interest in a new simple surgical descriptive system for endometriosis. Of particular focus were three systems most commonly used: the Revised American Society for Reproductive Medicine (rASRM) classification, the Endometriosis Fertility Index (EFI), and the ENZIAN classification. Data were analysed by SPSS. A survey was designed using the online SurveyMonkey tool consisting of 11 questions concerning three domains— participants’ background, existing classification systems and intentions with regards to a new classification system for endometriosis. Replies were collected between 15 May and 1 July 2020.
Uptake, feedback and future intentions.
The final dataset included the replies of 1178 clinicians, including surgeons, gynaecologists, reproductive endocrinologists, fertility specialists and sonographers, all managing women with endometriosis in their clinical practice. Overall, 75.5% of the professionals indicate that they currently use a classification system for endometriosis. The rASRM classification system was the best known and used system, the EFI system and ENZIAN system were known by a majority of the professionals but used by only a minority. The lack of clinical relevance was most often selected as a problem with using any system. The findings of the survey suggest that clinicians worldwide are open to using a new classification system for endometriosis that can achieve standardised reporting, and is clinically relevant and simple.
Even with a high uptake of the existing endometriosis classification systems (rASRM, ENZIAN and EFI), most clinicians managing endometriosis would like a new simple surgical descriptive system for endometriosis.
WHAT IS NEW?: The findings therefore support future initiatives for the development of a new descriptive system for endometriosis and provide information on user expectations and conditions for universal uptake of such a system.
在子宫内膜异位症领域，已经开发并发布了几种分类、分期和报告系统，但尚无关于这些系统在临床实践中应用情况的数据。
本研究的目的是调查临床医生是否常规使用现有的子宫内膜异位症分类系统，他们使用哪种系统以及临床医生的动机是什么？
进行了一项横断面研究，以收集有关子宫内膜异位症分类系统当前使用情况、遇到的问题以及对一种新的简单手术描述性子宫内膜异位症系统的兴趣的数据。特别关注最常用的三种系统：修订后的美国生殖医学学会（rASRM）分类、子宫内膜异位症生育指数（EFI）和恩齐安分类。数据采用SPSS进行分析。使用在线SurveyMonkey工具设计了一项调查，包括11个关于三个领域的问题——参与者背景、现有分类系统以及对新的子宫内膜异位症分类系统的意向。在2020年5月15日至7月1日期间收集回复。
应用情况、反馈和未来意向。
最终数据集包括1178名临床医生的回复，这些医生包括外科医生、妇科医生、生殖内分泌学家、生育专家和超声医师，他们在临床实践中均诊治患有子宫内膜异位症的女性。总体而言，75.5%的专业人员表示他们目前使用子宫内膜异位症分类系统。rASRM分类系统是最广为人知且使用的系统，大多数专业人员知晓EFI系统和恩齐安系统，但只有少数人使用。使用任何系统时，最常被选为问题的是缺乏临床相关性。调查结果表明，全球临床医生愿意使用一种新的子宫内膜异位症分类系统，该系统能够实现标准化报告，且具有临床相关性且简单。
即使现有子宫内膜异位症分类系统（rASRM、恩齐安和EFI）的应用率较高，但大多数诊治子宫内膜异位症的临床医生仍希望有一个新的简单手术描述性子宫内膜异位症系统。
新发现是什么？：因此，这些发现支持未来开发新的子宫内膜异位症描述系统的倡议，并提供了关于用户期望以及该系统普遍应用条件的信息。
